Showing results (1211-1220 of 4,388) with videos related to
Sort By:
Pageof 439
Journal of Analytical Toxicology|November 2, 2004
Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samplesJustin M Holler, Thomas Z Bosy, Kevin L Klette, et al.Journal of Analytical Toxicology|November 2, 2004
A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasmaDavid E Moody, John D Laycock, Wei Huang, et al.Journal of Analytical Toxicology|November 2, 2004
Fatal overdoses associated with quetiapineLoralie J Langman, Henry A Kaliciak, Sheila CarlyleJournal of Analytical Toxicology|November 2, 2004
Development of a method for the detection and confirmation of the alpha-2 agonist amitraz and its major metabolite in horse urineA F Lehner, C G Hughes, W Karpiesiuk, et al.Journal of Analytical Toxicology|November 2, 2004
Determination of the benzodiazepine plasma concentrations in suicidal patients using a radioreceptor assayLutea A A de Jong, Bas Verwey, Guus Essink, et al.Journal of Analytical Toxicology|November 2, 2004
Evaluation of Roche Diagnostics ONLINE DAT II, a new generation of assays for the detection of drugs of abuseM Feldman, D Kuntz, K Botelho, et al.Journal of Analytical Toxicology|November 2, 2004
Six spectroscopic methods for detection of oxidants in urine: implication in differentiation of normal and adulterated urineBuddha D PaulJournal of Analytical Toxicology|August 18, 2005
GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in bloodRobert MeatherallJournal of Analytical Toxicology|August 18, 2005
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THCAnnick Ménétrey, Marc Augsburger, Bernard Favrat, et al.Journal of Analytical Toxicology|August 18, 2005
Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerationsPiotr Adamowicz, Maria KalaPageof 439